Related references
Note: Only part of the references are listed.Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors
Vanessa Escuret et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo
Hui-Ling Yen et al.
JOURNAL OF VIROLOGY (2007)
The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance
Lone Simonsen et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
Varough M. Deyde et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir
M. A. Rameix-Welti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J. Russell et al.
NATURE (2006)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
RA Bright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors
VP Mishin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
P Ward et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons
BA Mungall et al.
VIRUS RESEARCH (2004)
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs
AC Hurt et al.
VIRUS RESEARCH (2004)
Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets
ML Herlocher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Overexpression of the α-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors
M Matrosovich et al.
JOURNAL OF VIROLOGY (2003)
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
J McKimm-Breschkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: Report of the neuraminidase inhibitor susceptibility network
NT Wetherall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir
MZ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
JAL Ives et al.
ANTIVIRAL RESEARCH (2002)
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
R Wagner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
